Heartflow received nationwide UnitedHealthcare coverage for its AI CT plaque analysis software and announced plans for a $200M IPO at a $1.3B valuation.
Key Details
- 1UnitedHealthcare will provide nationwide coverage for Heartflow's CT-based plaque analysis software, effective October 1.
- 2Coverage applies to all UnitedHealthcare plans, including commercial, Medicare Advantage, and dual-eligible offerings.
- 3Heartflow aims to raise up to $212.5 million by offering 12.5 million shares at $15–$17 per share in its IPO.
- 4Company generated about $43 million in Q2 2025, up 40% year-over-year.
- 5Heartflow's platform has assessed over 400,000 patients for coronary artery disease as of March 31, 2025.
- 6The US market opportunity for Heartflow's products is estimated at $5 billion.
Why It Matters
Nationwide insurer coverage and a strong IPO position solidify Heartflow's AI solution as a standard in coronary CT interpretation. This represents a significant step in the adoption and reimbursement of radiology AI, paving the way for broader clinical and commercial implementation.
Source
Radiology Business
Related News
•AuntMinnie
ChatGPT-4 Turbo Powers Postdeployment Monitoring of ICH Detection AI
Researchers found ChatGPT-4 Turbo could efficiently monitor the performance of Aidoc's ICH detection AI across real-world radiology practices.
•Radiology Business
Heartflow Raises $364M in Highly Subscribed Public Offering
Cardiac imaging AI company Heartflow raised $364 million from an upsized public stock offering, far exceeding expectations.
•AuntMinnie
United Healthcare Adds Coverage for Elucid's PlaqueIQ AI Platform
United Healthcare will begin covering Elucid's PlaqueIQ coronary CTA plaque quantification AI software starting October 1.